"10.1371_journal.pone.0074037","plos one","2013-09-09T00:00:00Z","Danielle E Clarkesmith; Helen M Pattison; Gregory Y H Lip; Deirdre A Lane","University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; School of Health and Life Sciences, Aston University, Birmingham, United Kingdom","Conceived and designed the experiments: DEC DAL HMP GYHL. Performed the experiments: DEC DAL. Analyzed the data: DEC DAL HMP. Contributed reagents/materials/analysis tools: DEC DAL HMP GYHL. Wrote the manuscript: DEC DAL HMP GYHL.","DAL is in receipt of an investigator-initiated educational grant from Bayer Healthcare and has been on the speakers bureau for Boehringer Ingelheim, BMS/Pfizer, and Bayer Healthcare.  She is also a Steering Committee member for the AEGEAN study.  The investigator-initiated educational grant from Bayer Healthcare funded the TREAT study.  GYHL has served as a consultant for Bayer, Astellas, Merck, Sanofi-Aventis, BMS/Pfizer, Daiichi-Sankyo, Biotronik, Portola, and Boehringer Ingelheim and has been on the speakers bureau for Bayer, BMS/Pfizer, Boehringer Ingelheim, and Sanofi-Aventis.  DECs PhD studentship to conduct the TREAT study was partly funded by the Investigator-initiated educational grant awarded to DAL by Bayer Healthcare.  HMP has no conflicts of interest to declare in relation to this manuscript.  The authors reported conflicts of interest do not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.",1,0,0,"2013","09","Danielle E Clarkesmith","DEC",4,TRUE,4,2,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
